Clinical Trials Directory

Trials / Completed

CompletedNCT05148065

Frequency Analysis of Raw EEG During Sevoflurane Anesthesia in Children Younger Than 2 Years Old

Analysis of Relationship Between Depth of Anesthesia by Inhalation Anesthetic and Primitive Electroencephalogram in Children Under Two Years of Age: a Prospective Observational Study

Status
Completed
Phase
Study type
Observational
Enrollment
50 (actual)
Sponsor
Sang-Hwan Ji · Academic / Other
Sex
All
Age
4 Months – 23 Months
Healthy volunteers
Not accepted

Summary

The purpose of this study is to analyze raw electroencephalogram in infants younger than 2 years old undergoing general anesthesia using sevoflurane.

Detailed description

After obtaining an informed consent from one of the parents, patients undergo routine anesthetic induction using sodium thiopental. Bispectral index and patient state index are both monitored simultaneously. Raw electroencephalogram data are transmitted and recorded via a dedicated equipment. Anesthesia is maintained using sevoflurane with end-tidal level of less than 2 minimum alveolar concentration (MAC) adjusted to age. Fentanyl of up to 1 mcg/kg can be administered in case of increased heart rate and mean blood pressure with a degree of 30% of baseline. During anesthesia, patients' status of sedation is defined as 'maintenance of surgical state of anesthesia (MOSSA)' when the end-tidal concentration of sevoflurane is maintained between 0.7 and 1.3 MAC and mean blood pressure and heart rate is between 80-120% of baseline. 'Emergence' is defined as a 3-minute period in the middle of continuous decrease in end-tidal concentration of sevoflurane in the range of less than 0.7 MAC and finally reaching 0.2 MAC. Raw electroencephalogram waves are analyzed by distribution of power along frequency bands and compared according to the state of anesthesia or bispectral index / patient state index value.

Conditions

Interventions

TypeNameDescription
DEVICEBISBispectral index monitoring
DEVICEPSiPatient state index monitoring

Timeline

Start date
2021-12-15
Primary completion
2023-05-15
Completion
2023-05-15
First posted
2021-12-08
Last updated
2023-06-09

Locations

1 site across 1 country: South Korea

Regulatory

Source: ClinicalTrials.gov record NCT05148065. Inclusion in this directory is not an endorsement.